Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELI domain containing 3B pseudogene 6 (PRELID3BP6) is a *processed human pseudogene*, meaning it has sequence similarity to a functional coding gene but lacks the ability to produce a functional protein due to features such as premature stop codons, frameshifts, or absence of necessary regulatory elements. Like most pseudogenes, it does **not have an established biological or therapeutic role** and is not recognized as a receptor or drug target. While some pseudogenes have regulatory functions or have been implicated in disease, PRELID3BP6 itself has no confirmed function or clinical relevance and is mainly catalogued as a genomic relic[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing 3B pseudogene 6 (PRELID3BP6).